The Prospective Randomized On-X Valve Anticoagulation Clinical Trial (PROACT)
A longitudinal, randomized study comparing the On-X valve on low dose anticoagulation (test group) to concomitant control groups of On-X valves receiving standard Coumadin/aspirin therapy.
Heart & Vascular - Cardiac Surgery
Glenn Barnhart, MD
Patients who require either aortic valve replacement or mitral valve replacement (MVR) and who are receiving low dose antiplatelet/anticoagulation therapy. Patients needing both aortic and mitral valves replaced or who have certain diagnoses may be excluded.
Charlene Boisjolie and Jennifer Nagel